Ptc Therapeutics (PTCT) EPS (Basic) Growth (3y) (2015 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) EPS (Basic) Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 86.03% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 18.44% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 37.21% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 36.73% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | -38.31% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 67.51% |
| 10 | Ptc Therapeutics | 5.79 Bn | 3.56 Bn | 340.60 Mn | 33.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.48% |
| Mar 31, 2026 | 73.76% |
| Dec 31, 2025 | 51.96% |
| Sep 30, 2025 | 28.72% |
| Jun 30, 2025 | 26.98% |
| Mar 31, 2025 | 101.93% |
| Dec 31, 2024 | 25.01% |
| Sep 30, 2024 | 9.86% |
| Jun 30, 2024 | 8.38% |
| Mar 31, 2024 | 13.24% |
| Dec 31, 2023 | -3.52% |
| Sep 30, 2023 | -19.63% |
| Jun 30, 2023 | 1.50% |
| Mar 31, 2023 | -1.43% |
| Dec 31, 2022 | -21.77% |
| Sep 30, 2022 | -12.81% |
| Jun 30, 2022 | -41.80% |
| Mar 31, 2022 | -11.29% |
| Dec 31, 2021 | -24.54% |
| Sep 30, 2021 | -21.34% |